These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 35060503)
1. Prognostic value of EGFR and p-EGFR in nasopharyngeal carcinoma: A systematic review and meta-analysis. Hong X; Wang G; Xu G; Shi W; Wang T; Rong Z; Mo C Medicine (Baltimore); 2022 Jan; 101(3):e28507. PubMed ID: 35060503 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis. Chen X; Liang R; Lai L; Chen K; Zhu X Front Oncol; 2021; 11():697369. PubMed ID: 34490092 [TBL] [Abstract][Full Text] [Related]
3. Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: a meta-analysis. Sun W; Long G; Wang J; Mei Q; Liu D; Hu G Head Neck; 2014 Oct; 36(10):1508-16. PubMed ID: 23996630 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients. Tu X; Ren J; Zhao Y Oral Oncol; 2020 Nov; 110():104991. PubMed ID: 32919361 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysis. Zhang M; Wei S; Su L; Lv W; Hong J Medicine (Baltimore); 2016 Aug; 95(35):e4494. PubMed ID: 27583859 [TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma. Cao Y; Chan KI; Xiao G; Chen Y; Qiu X; Hao H; Mak SC; Lin T BMC Cancer; 2019 Oct; 19(1):1022. PubMed ID: 31664962 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature. Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis. Zhang Y; Yang X Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Tumor Infiltrating Lymphocytes in Nasopharyngeal Carcinoma Patients: Meta-Analysis. Berele BA; Cai Y; Yang G Technol Cancer Res Treat; 2021; 20():15330338211034265. PubMed ID: 34323154 [TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients. Liu LT; Chen QY; Tang LQ; Guo SS; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Qian CN; Zeng MS; Bei JX; Tan J; Chen S; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ Cancer Res Treat; 2018 Jan; 50(1):19-29. PubMed ID: 28392551 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the EGFR pathway in nasopharyngeal carcinoma: a systematic review and meta-analysis. Ooft ML; Braunius WW; Heus P; Stegeman I; van Diest PJ; Grolman W; Zuur CI; Willems SM Biomark Med; 2015; 9(10):997-1010. PubMed ID: 26441207 [TBL] [Abstract][Full Text] [Related]
12. Combined chemoradiation vs radiation therapy alone in stage-II nasopharyngeal carcinoma: A meta-analysis of the published literature. Wang S; Li S; Shen L Curr Probl Cancer; 2018; 42(3):302-318. PubMed ID: 29759802 [TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis. Zhou R; Zhu J; Chen X; Liu Y; Wang Y; Zhang T Clin Transl Oncol; 2020 Mar; 22(3):429-439. PubMed ID: 31165410 [TBL] [Abstract][Full Text] [Related]
14. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis. Su L; Zhang M; Zhang W; Cai C; Hong J Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of Ki-67 in nasopharyngeal carcinoma: a meta-analysis. Li Y; Yue L; Li Y; Zhang Q; Liang X Biosci Rep; 2021 May; 41(5):. PubMed ID: 33393626 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of cervical nodal necrosis on staging imaging of nasopharyngeal carcinoma in era of intensity-modulated radiotherapy: a systematic review and meta-analysis. Ai QH; Hung KF; So TY; Mo FKF; Tsung Anthony Chin W; Hui EP; Ma BBY; Ying M; King AD Cancer Imaging; 2022 May; 22(1):24. PubMed ID: 35596198 [TBL] [Abstract][Full Text] [Related]
17. Treatment Protocols in the Efficacy and Safety of Anti-EGFR Medicines in Combination with Standard Therapy for Patients with Nasopharyngeal Cancer: A Meta-Analysis. Fang Y; Fan J; Yan C Biomed Res Int; 2023; 2023():9477442. PubMed ID: 36794258 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Serum Lactate Dehydrogenase in Patients with Nasopharyngeal Carcinoma: a Meta-Analysis. Zhai C; Gu K; Zhai X; Wang J; Zhang J Clin Lab; 2017 Nov; 63(11):1777-1785. PubMed ID: 29226643 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a treatment in patients with locoregionally advanced nasopharyngeal carcinoma (LANC) involving carotid artery invasion. Liu K; Wang Y; Ma L; Yang S; Zhang X Eur Arch Otorhinolaryngol; 2022 Dec; 279(12):5791-5799. PubMed ID: 35918541 [TBL] [Abstract][Full Text] [Related]
20. Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis. Keren S; Shoude Z; Lu Z; Beibei Y Tumour Biol; 2014 Mar; 35(3):2285-95. PubMed ID: 24234257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]